These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20624928)
1. Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1. Gimm T; Wiese M; Teschemacher B; Deggerich A; Schödel J; Knaup KX; Hackenbeck T; Hellerbrand C; Amann K; Wiesener MS; Höning S; Eckardt KU; Warnecke C FASEB J; 2010 Nov; 24(11):4443-58. PubMed ID: 20624928 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Togashi A; Katagiri T; Ashida S; Fujioka T; Maruyama O; Wakumoto Y; Sakamoto Y; Fujime M; Kawachi Y; Shuin T; Nakamura Y Cancer Res; 2005 Jun; 65(11):4817-26. PubMed ID: 15930302 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice. Maier A; Wu H; Cordasic N; Oefner P; Dietel B; Thiele C; Weidemann A; Eckardt KU; Warnecke C FASEB J; 2017 Nov; 31(11):4971-4984. PubMed ID: 28760743 [TBL] [Abstract][Full Text] [Related]
4. MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. Aubert S; Fauquette V; Hémon B; Lepoivre R; Briez N; Bernard D; Van Seuningen I; Leroy X; Perrais M Cancer Res; 2009 Jul; 69(14):5707-15. PubMed ID: 19549898 [TBL] [Abstract][Full Text] [Related]
7. Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia. Triantafyllou EA; Georgatsou E; Mylonis I; Simos G; Paraskeva E Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1142-1152. PubMed ID: 29908837 [TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362 [TBL] [Abstract][Full Text] [Related]
9. HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways. Kim SH; Wang D; Park YY; Katoh H; Margalit O; Sheffer M; Wu H; Holla VR; Lee JS; DuBois RN Cancer Lett; 2013 Dec; 341(2):159-65. PubMed ID: 23916472 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway. Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma. Xu W; Zhou W; Cheng M; Wang J; Liu Z; He S; Luo X; Huang W; Chen T; Yan W; Xiao J Sci Rep; 2017 Jan; 7():40446. PubMed ID: 28074862 [TBL] [Abstract][Full Text] [Related]
12. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia. Zhang X; Saarinen AM; Hitosugi T; Wang Z; Wang L; Ho TH; Liu J Elife; 2017 Dec; 6():. PubMed ID: 29256392 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells. Bai H; Ge S; Lu J; Qian G; Xu R J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma. Gao YH; Li CX; Shen SM; Li H; Chen GQ; Wei Q; Wang LS Biochem Biophys Res Commun; 2013 May; 435(1):46-51. PubMed ID: 23611775 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of hypoxia-inducible protein 2 among different histological types of epithelial ovarian cancer and in clear cell adenocarcinomas. Nishimura S; Tsuda H; Ito K; Takano M; Terai Y; Jobo T; Kigawa J; Sugiyama T; Yaegashi N; Aoki D Int J Gynecol Cancer; 2010 Feb; 20(2):220-6. PubMed ID: 20134266 [TBL] [Abstract][Full Text] [Related]
19. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma. Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846 [TBL] [Abstract][Full Text] [Related]